case 3: molecular testing in relapsed myeloma
Published 5 years ago • 38 plays • Length 4:59Download video MP4
Download video MP3
Similar videos
-
5:45
case 3: treatment for relapsed myeloma with 17p deletion
-
3:07
case 4: molecular testing and car t-cell therapy in myeloma
-
3:58
case 1: molecular testing in myeloma
-
2:43
case 2: evolution of molecular testing in myeloma
-
7:30
biochemical relapse of multiple myeloma
-
2:24
the importance of molecular testing in multiple myeloma and how this may impact future treatment
-
3:19
bcma-targeted therapy in rrmm: results from the dreamm-1 trial
-
1:05
evaluating control regimens in phase iii clinical trials for early-relapsed multiple myeloma
-
5:49
testing and therapy options for relapsed stage ii multiple myeloma
-
1:35
comparing results for 3-drug and 2-drug regimens in relapsed/refractory myeloma
-
32:06
relapsed myeloma, treatment for relapsed myeloma, drugs in development, knowledge post-test
-
2:04
pomalidomide-based triplets improve responses in relapsed/refractory multiple myeloma
-
2:39
case 4: relapsed-refractory myeloma
-
4:06
case 4: car t-cell therapy in myeloma
-
4:09
case 1: consolidation therapy in myeloma
-
9:14
efficacy and safety of elranatamab in pts with relapsed/refractory multiple myeloma: magnetismm-3
-
1:12
causes for relapse in multiple myeloma with car t cells
-
6:33
treatment of myeloma relapsed disease
-
20:29
multiple myeloma - case presentations